Cargando…
Novel Antigenic Targets of HPV Therapeutic Vaccines
Human papillomavirus (HPV) infection is the cause of the majority of cervical cancers and head and neck cancers worldwide. Although prophylactic vaccines and cervical cancer screening programs have shown efficacy in preventing HPV-associated cervical cancer, cervical cancer is still a major cause of...
Autores principales: | Boilesen, Ditte Rahbæk, Nielsen, Karen Nørgaard, Holst, Peter Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621534/ https://www.ncbi.nlm.nih.gov/pubmed/34835193 http://dx.doi.org/10.3390/vaccines9111262 |
Ejemplares similares
-
Design and Immunological Validation of Macaca fascicularis Papillomavirus Type 3 Based Vaccine Candidates in Outbred Mice: Basis for Future Testing of a Therapeutic Papillomavirus Vaccine in NHPs
por: Neckermann, Patrick, et al.
Publicado: (2021) -
A Systematic Review of Expression and Immunogenicity of Human Endogenous Retroviral Proteins in Cancer and Discussion of Therapeutic Approaches
por: Müller, Mikkel Dons, et al.
Publicado: (2022) -
Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication
por: Xu, Huanbin, et al.
Publicado: (2017) -
Comment on: Endogenous retroviruses expressed in human tumours cannot be used as targets for anti-tumour vaccines
por: Bermejo, Amaia Vergara, et al.
Publicado: (2021) -
Anti-Cancer Vaccine for HPV-Associated Neoplasms: Focus on a Therapeutic HPV Vaccine Based on a Novel Tumor Antigen Delivery Method Using Endogenously Engineered Exosomes
por: Di Bonito, Paola, et al.
Publicado: (2019)